Asia Morning August 20
Federal Reserve officials expect the economy to require "additional accommodation" for recovering from the coronavirus pandemic...
Share this:
On Wednesday, U.S. stocks ended in the red. The Dow Jones Industrial Average fell 85 points (-0.31%) to 27692, the S&P 500 dropped 14 points (-0.44%) to 3374, and the Nasdaq 100 was down 80 points (-0.71%) to 11318.
Dow Jones Industrial Average: Daily Chart
Sources: GAIN Capital, TradingView
Real Estate (-2.02%), Automobiles & Components (-1.44%) and Energy (-1.16%) sectors lost the most. Target (TGT +12.65%) gapped up to an all-time high after reporting upbeat second-quarter results. Meanwhile, Jack Henry & Associates (JKHY -12.87%), TJX Companies (TJX -5.38%) and Gilead Sciences (GILD -4.87%) were top losers.
Shares of Momenta Pharmaceuticals (MNTA +69.17%) soared after Johnson & Johnson (JNJ +0.20%) agreed to acquire the company for $6.50 billion or $52.50 per share.
Approximately 60.8% (61.0% in the prior session) of stocks in the S&P 500 Index were trading above their 200-day moving average and 71.3% (76.4% in the prior session) were trading above their 20-day moving average.
Minutes from the U.S. Federal Reserve's latest meeting showed that officials expected the economy to require "additional accommodation" for recovering from the coronavirus pandemic.
Later today, investors will watch closely numbers of Initial Jobless Claims (a decline to 920,000 expected) and Continuing Claims (a fall to 15.00 million expected). The Conference Board Leading Index will also be released (+1.1% on month in July expected).
European stocks rebounded. The Stoxx Europe 600 Index rose 0.65%. Germany's DAX 30 increased 0.74%, France's CAC 40 gained 0.79%, and the U.K.'s FTSE 100 added 0.58%.
U.S. government bond prices eased, as the benchmark 10-year Treasury yield climbed to 0.685% from 0.662% Tuesday.
Spot gold lost again the key level of $2,000 an ounce, as it slumped $73.00 (-3.67%) to $1,929 an ounce. Spot silver shed 3.52% to $26.70 an ounce.
U.S. WTI crude oil futures (September) edged up 0.1% to $42.93 a barrel.
On the forex front, the ICE U.S. Dollar Index rebounded 0.9% on day to 93.00, halting a five-day decline, as the latest Federal Reserve's FOMC meeting minutes showed little guidance to future monetary policy path.
EUR/USD retreated 0.7% to 1.1847, following a five-day rally.
GBP/USD slid 0.9% to 1.3110. Official data showed that U.K. CPI grew 1.0% on year in July (+0.6% expected).
USD/JPY bounced 0.6% to 106.04.
USD/CAD climbed 0.4% to 1.3213. Government data showed that Canada's CPI grew 0.1% on year in July (+0.5% expected).
Other commodity-linked currencies were broadly lower against the greenback. AUD/USD dropped 0.8% to 0.7186 and NZD/USD was down 0.6% to 0.6562.
Dow Jones Industrial Average: Daily Chart
Sources: GAIN Capital, TradingView
Real Estate (-2.02%), Automobiles & Components (-1.44%) and Energy (-1.16%) sectors lost the most. Target (TGT +12.65%) gapped up to an all-time high after reporting upbeat second-quarter results. Meanwhile, Jack Henry & Associates (JKHY -12.87%), TJX Companies (TJX -5.38%) and Gilead Sciences (GILD -4.87%) were top losers.
Shares of Momenta Pharmaceuticals (MNTA +69.17%) soared after Johnson & Johnson (JNJ +0.20%) agreed to acquire the company for $6.50 billion or $52.50 per share.
Approximately 60.8% (61.0% in the prior session) of stocks in the S&P 500 Index were trading above their 200-day moving average and 71.3% (76.4% in the prior session) were trading above their 20-day moving average.
Minutes from the U.S. Federal Reserve's latest meeting showed that officials expected the economy to require "additional accommodation" for recovering from the coronavirus pandemic.
Later today, investors will watch closely numbers of Initial Jobless Claims (a decline to 920,000 expected) and Continuing Claims (a fall to 15.00 million expected). The Conference Board Leading Index will also be released (+1.1% on month in July expected).
European stocks rebounded. The Stoxx Europe 600 Index rose 0.65%. Germany's DAX 30 increased 0.74%, France's CAC 40 gained 0.79%, and the U.K.'s FTSE 100 added 0.58%.
U.S. government bond prices eased, as the benchmark 10-year Treasury yield climbed to 0.685% from 0.662% Tuesday.
Spot gold lost again the key level of $2,000 an ounce, as it slumped $73.00 (-3.67%) to $1,929 an ounce. Spot silver shed 3.52% to $26.70 an ounce.
U.S. WTI crude oil futures (September) edged up 0.1% to $42.93 a barrel.
On the forex front, the ICE U.S. Dollar Index rebounded 0.9% on day to 93.00, halting a five-day decline, as the latest Federal Reserve's FOMC meeting minutes showed little guidance to future monetary policy path.
EUR/USD retreated 0.7% to 1.1847, following a five-day rally.
GBP/USD slid 0.9% to 1.3110. Official data showed that U.K. CPI grew 1.0% on year in July (+0.6% expected).
USD/JPY bounced 0.6% to 106.04.
USD/CAD climbed 0.4% to 1.3213. Government data showed that Canada's CPI grew 0.1% on year in July (+0.5% expected).
Other commodity-linked currencies were broadly lower against the greenback. AUD/USD dropped 0.8% to 0.7186 and NZD/USD was down 0.6% to 0.6562.
On Wednesday, U.S. stocks ended in the red. The Dow Jones Industrial Average fell 85 points (-0.31%) to 27692, the S&P 500 dropped 14 points (-0.44%) to 3374, and the Nasdaq 100 was down 80 points (-0.71%) to 11318.
Dow Jones Industrial Average: Daily Chart
Sources: GAIN Capital, TradingView
Real Estate (-2.02%), Automobiles & Components (-1.44%) and Energy (-1.16%) sectors lost the most. Target (TGT +12.65%) gapped up to an all-time high after reporting upbeat second-quarter results. Meanwhile, Jack Henry & Associates (JKHY -12.87%), TJX Companies (TJX -5.38%) and Gilead Sciences (GILD -4.87%) were top losers.
Shares of Momenta Pharmaceuticals (MNTA +69.17%) soared after Johnson & Johnson (JNJ +0.20%) agreed to acquire the company for $6.50 billion or $52.50 per share.
Approximately 60.8% (61.0% in the prior session) of stocks in the S&P 500 Index were trading above their 200-day moving average and 71.3% (76.4% in the prior session) were trading above their 20-day moving average.
Minutes from the U.S. Federal Reserve's latest meeting showed that officials expected the economy to require "additional accommodation" for recovering from the coronavirus pandemic.
Later today, investors will watch closely numbers of Initial Jobless Claims (a decline to 920,000 expected) and Continuing Claims (a fall to 15.00 million expected). The Conference Board Leading Index will also be released (+1.1% on month in July expected).
European stocks rebounded. The Stoxx Europe 600 Index rose 0.65%. Germany's DAX 30 increased 0.74%, France's CAC 40 gained 0.79%, and the U.K.'s FTSE 100 added 0.58%.
U.S. government bond prices eased, as the benchmark 10-year Treasury yield climbed to 0.685% from 0.662% Tuesday.
Spot gold lost again the key level of $2,000 an ounce, as it slumped $73.00 (-3.67%) to $1,929 an ounce. Spot silver shed 3.52% to $26.70 an ounce.
U.S. WTI crude oil futures (September) edged up 0.1% to $42.93 a barrel.
On the forex front, the ICE U.S. Dollar Index rebounded 0.9% on day to 93.00, halting a five-day decline, as the latest Federal Reserve's FOMC meeting minutes showed little guidance to future monetary policy path.
EUR/USD retreated 0.7% to 1.1847, following a five-day rally.
GBP/USD slid 0.9% to 1.3110. Official data showed that U.K. CPI grew 1.0% on year in July (+0.6% expected).
USD/JPY bounced 0.6% to 106.04.
USD/CAD climbed 0.4% to 1.3213. Government data showed that Canada's CPI grew 0.1% on year in July (+0.5% expected).
Other commodity-linked currencies were broadly lower against the greenback. AUD/USD dropped 0.8% to 0.7186 and NZD/USD was down 0.6% to 0.6562.
Dow Jones Industrial Average: Daily Chart
Sources: GAIN Capital, TradingView
Real Estate (-2.02%), Automobiles & Components (-1.44%) and Energy (-1.16%) sectors lost the most. Target (TGT +12.65%) gapped up to an all-time high after reporting upbeat second-quarter results. Meanwhile, Jack Henry & Associates (JKHY -12.87%), TJX Companies (TJX -5.38%) and Gilead Sciences (GILD -4.87%) were top losers.
Shares of Momenta Pharmaceuticals (MNTA +69.17%) soared after Johnson & Johnson (JNJ +0.20%) agreed to acquire the company for $6.50 billion or $52.50 per share.
Approximately 60.8% (61.0% in the prior session) of stocks in the S&P 500 Index were trading above their 200-day moving average and 71.3% (76.4% in the prior session) were trading above their 20-day moving average.
Minutes from the U.S. Federal Reserve's latest meeting showed that officials expected the economy to require "additional accommodation" for recovering from the coronavirus pandemic.
Later today, investors will watch closely numbers of Initial Jobless Claims (a decline to 920,000 expected) and Continuing Claims (a fall to 15.00 million expected). The Conference Board Leading Index will also be released (+1.1% on month in July expected).
European stocks rebounded. The Stoxx Europe 600 Index rose 0.65%. Germany's DAX 30 increased 0.74%, France's CAC 40 gained 0.79%, and the U.K.'s FTSE 100 added 0.58%.
U.S. government bond prices eased, as the benchmark 10-year Treasury yield climbed to 0.685% from 0.662% Tuesday.
Spot gold lost again the key level of $2,000 an ounce, as it slumped $73.00 (-3.67%) to $1,929 an ounce. Spot silver shed 3.52% to $26.70 an ounce.
U.S. WTI crude oil futures (September) edged up 0.1% to $42.93 a barrel.
On the forex front, the ICE U.S. Dollar Index rebounded 0.9% on day to 93.00, halting a five-day decline, as the latest Federal Reserve's FOMC meeting minutes showed little guidance to future monetary policy path.
EUR/USD retreated 0.7% to 1.1847, following a five-day rally.
GBP/USD slid 0.9% to 1.3110. Official data showed that U.K. CPI grew 1.0% on year in July (+0.6% expected).
USD/JPY bounced 0.6% to 106.04.
USD/CAD climbed 0.4% to 1.3213. Government data showed that Canada's CPI grew 0.1% on year in July (+0.5% expected).
Other commodity-linked currencies were broadly lower against the greenback. AUD/USD dropped 0.8% to 0.7186 and NZD/USD was down 0.6% to 0.6562.
Related tags:
Latest market news
The complete CFD trading experience
Award-winning platforms, competitive spreads, low commissions and dedicated support.
We live and breathe the markets and are dedicated to helping traders realise their ambitions as we continue to set the industry bar.
Economic calendar
Web Trader platform
Our sophisticated web-based platform is packed with features.
Related articles
EUR/USD weekly outlook: Oil, inflation and NFP in focus
After coming under significant pressure in recent weeks, the EUR/USD came off its lows to finish the week on a positive note on Friday, albeit with only a mild rebound. That was not enough to prevent the exchange rate falling for the third consecutive week, as the US dollar and bond yields rallied across the board.
EUR/USD Q4 2026 Outlook: Euro at a Crossroads as Fed, ECB Tighten 9 25 2026
EUR/USD enters Q4 at a pivotal inflection point as competing Fed-ECB policy paths and persistent inflation risks collide with major technical support.
USD/JPY Q4 2026 Outlook: Hawkish Fed Pricing Clashes With Intervention Risk
The year-end tug-of-war is clear: hawkish Fed pricing supports USD/JPY, while intervention risk limits the upside.
StoneX Europe Ltd may make third party material available on this website which may contain information included but not limited to the conditions of financial markets. The material is for information purposes only and does not contain, and should not be construed as containing, investment advice and/or investment recommendation and/or an investment research and/or an offer of or solicitation for any transactions in financial instruments; any decision to enter into a specific transaction shall be made by the client following an assessment by him/her of their situation.
StoneX Europe Ltd makes no representation or warranty and assumes no liability as to the accuracy or completeness of the information provided, nor any loss arising from any investment based on a recommendation, forecast or other information supplied. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. We are not under any obligation to update any such material. Any opinion made may be personal to the author and may not reflect the opinion of StoneX Europe Ltd.